v3.26.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities    
Net loss $ (3,230,842) $ (1,299,619)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 17,816 16,600
Amortization 155,789 77,894
Amortization of debt discount 414,797 491,700
Stock based compensation expense 958,163 70,051
Financing cost 308,236 0
Change in fair value of derivative financial instruments (541,886) 0
Changes in assets and liabilities    
Prepaid Expenses (16,057) 0
Right of use lease asset 36,861 13,298
Accounts payable 1,021,656 (188,560)
Accrued interest 44,674 (14,004)
Lease liability (36,861) (13,298)
Due to related party 35,624 74,572
Net cash used in operating activities (832,030) (771,366)
Cash Flows from Investing Activities    
Acquisition of fixed assets (66,229) 0
Net cash used in investing activities (66,229) 0
Cash Flows from Financing Activities    
Proceeds from the issuance of common shares for cash 192,355 0
Proceeds from the issuance of preferred shares for cash 210,000 0
Proceeds from issuance of convertible notes and promissory notes 579,500 843,200
Repayment of promissory notes (130,000) (55,000)
Net cash provided by financing activities 851,855 788,200
Net (Decrease) Increase in Cash (46,404) 16,834
Net Change in Cash    
Cash at beginning of period 54,009 33
Cash at end of period 7,605 16,867
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 0 14,004
Cash paid during the period for income tax 0 0
Schedule of non-cash investing and financing activities:    
Conversion of contingent equity consideration payable to equity 0 11,281,541
Conversion of Series A Preferred Stock to Common Stock 66 0
Conversion of convertible debt to equity 142,070 840,675
Recognition of operating lease: right of use asset and lease liability 0 96,347
Fair value of warrants issued as deferred offering cost 0 990,614
Fair value of convertible debt beneficial conversion feature allocated to proceeds of debt 695,188 491,700
Fair value of warrants allocated to proceeds of debt 98,773 0
Fair value of common shares allocated to proceeds of debt 12,971 0
Convertible note proceeds receivable from lender 75,000 0
Contingent equity consideration payable from acquisition $ 0 $ 3,323,192